Abstract
Diagnostic biomarkers in hepatocellular carcinoma
Highlights
Hepatocellular carcinoma (HCC) elucidates initial stage and its efficient treatment for more than 85-90% of primary cancer of enhance the lifetime of patients having liver liver and causes many deaths worldwide [1].cancer. 60-80% patients of HCC have aAmong the type of cancers, it is at number six condition called cirrhosis [5]
Cirrhosis there is a decrease in proliferation of
Earlier damage to liver cells which causes studies predict that analysis of HCC at the cancerous nodules [6]
Summary
Hepatocellular carcinoma (HCC) elucidates initial stage and its efficient treatment for more than 85-90% of primary cancer of enhance the lifetime of patients having liver liver and causes many deaths worldwide [1]. Among the type of cancers, it is at number six condition called cirrhosis [5]. In the case of liver known as the second most lethal cancer [4]. In early stages liver cancer shows no hepatocytes that reduce the liver regenerative symptoms, after its adequate progression capacity and leads to fibrous tissues and clinical symptoms are noticeable. Earlier damage to liver cells which causes studies predict that analysis of HCC at the cancerous nodules [6]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
